BRD1172
BRD1172 (ML320) is a selectivity GSK3β inhibitor with an IC50 of 24 nM for GSK3β over CDK5. BRD1172 significantly inhibits GSK3β-mediated Tau phosphorylation in SH-SY5Y cells, and relieves negative regulation by GSK3β on β-catenin degradation and TCF/LEF promoter activities. BRD1172 can be used for Alzheimer’s disease, cardiac hypertrophy and cancers research[1].
Product Specifications
CAS Number
1597438-86-2
Product Name Alternative
ML320
UNSPSC
12352005
Target
GSK-3; β-catenin
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Cancer; Neurological Disease; Cardiovascular Disease
Smiles
FC(F)(C1=C2[C@H](C3=C(C=CC=C3)OC)C4=C(CC(C)(CC4=O)C)NC2=NN1)F
Molecular Formula
C20H20F3N3O2
Molecular Weight
391.39
References & Citations
[1]An WF, et al. Discovery of Potent and Highly Selective Inhibitors of GSK3b. 2012 Apr 16 [updated 2014 May 13]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD) : National Center for Biotechnology Information (US) ; 2010–.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15111021 1 Vial
Lentiviral human SH3GL1 shRNA (UAS) - Lentiviral human SH3GL1 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details